{"id":"mycophenolate-tacrolimus-prednisone","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection (bacterial, viral, fungal)"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Bone loss / osteoporosis"}]},"_chembl":{"chemblId":"CHEMBL1456","moleculeType":"Small molecule","molecularWeight":"433.50"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mycophenolate inhibits inosine monophosphate dehydrogenase to reduce T and B cell proliferation. Tacrolimus blocks calcineurin signaling to prevent T-cell activation and cytokine production. Prednisone provides broad anti-inflammatory and immunosuppressive effects. Together, these agents work synergistically to prevent allograft rejection.","oneSentence":"This triple immunosuppressive regimen suppresses T-cell proliferation and activation to prevent organ rejection after transplantation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:56:15.901Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of organ rejection in renal transplant recipients"}]},"trialDetails":[{"nctId":"NCT07412470","phase":"PHASE2, PHASE3","title":"A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation","status":"RECRUITING","sponsor":"Sanofi","startDate":"2026-03-13","conditions":"Kidney Transplant Rejection","enrollment":526},{"nctId":"NCT05917522","phase":"PHASE2","title":"Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-12-07","conditions":"Kidney Transplant","enrollment":800},{"nctId":"NCT03663933","phase":"PHASE2","title":"Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-04","conditions":"Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders","enrollment":71},{"nctId":"NCT06918990","phase":"PHASE2","title":"Treatment of Antibody-Mediated Rejection (ABMR) With CarBel","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-15","conditions":"Kidney Transplant Rejection","enrollment":25},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT07430683","phase":"PHASE4","title":"Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2024-03-01","conditions":"Cytomegalovirus Infections","enrollment":68},{"nctId":"NCT04182984","phase":"","title":"TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2019-11-04","conditions":"Ocular Myasthenia Gravis","enrollment":200},{"nctId":"NCT03292861","phase":"PHASE2","title":"The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients","status":"ENROLLING_BY_INVITATION","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-09-13","conditions":"Heart Transplantation","enrollment":60},{"nctId":"NCT07297173","phase":"PHASE1","title":"Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2025-12-01","conditions":"Relapsed Leukemia, Refractory Leukemia","enrollment":5},{"nctId":"NCT04104438","phase":"PHASE4","title":"Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant","status":"COMPLETED","sponsor":"Fady M Kaldas, M.D., F.A.C.S.","startDate":"2021-01-15","conditions":"Asses Immunosuppression Modulation on Renal Recovery Post LT","enrollment":71},{"nctId":"NCT01241864","phase":"PHASE2","title":"Islet Transplantation in Type 1 Diabetic Kidney Allograft","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2010-12","conditions":"Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT01780844","phase":"PHASE2","title":"A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2013-03-05","conditions":"Kidney Transplantation","enrollment":149},{"nctId":"NCT04773392","phase":"PHASE4","title":"Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2021-11-23","conditions":"Kidney Transplantation, Kidney Transplant Rejection","enrollment":20},{"nctId":"NCT06478017","phase":"PHASE2","title":"Belatacept in Heart Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-01-29","conditions":"Heart Transplant","enrollment":66},{"nctId":"NCT07053462","phase":"PHASE1, PHASE2","title":"CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk","status":"RECRUITING","sponsor":"AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC","startDate":"2025-06-01","conditions":"End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant","enrollment":90},{"nctId":"NCT03726307","phase":"PHASE1","title":"Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Angus W. Thomson PhD DSc","startDate":"2019-04-10","conditions":"Kidney Transplant, Renal Transplant Recipients","enrollment":28},{"nctId":"NCT06280950","phase":"PHASE2","title":"Expanding Liver Transplant Immunosuppression Minimization Via Everolimus","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-09-12","conditions":"Liver Transplant","enrollment":340},{"nctId":"NCT04469842","phase":"EARLY_PHASE1","title":"Early Use of Long-acting Tacrolimus in Lung Transplant Recipients","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-12-01","conditions":"Lung Transplant; Complications","enrollment":48},{"nctId":"NCT02921789","phase":"PHASE2","title":"Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2017-05-22","conditions":"Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS)","enrollment":67},{"nctId":"NCT00717470","phase":"PHASE4","title":"A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2008-05-14","conditions":"Kidney Transplantation","enrollment":1252},{"nctId":"NCT00933231","phase":"PHASE3","title":"Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-08-17","conditions":"Kidney Transplantation","enrollment":281},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT06584773","phase":"PHASE4","title":"Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2015-06","conditions":"Disorder Related to Renal Transplantation","enrollment":80},{"nctId":"NCT04225988","phase":"PHASE4","title":"Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-01-09","conditions":"Kidney Transplant Rejection","enrollment":20},{"nctId":"NCT02426502","phase":"NA","title":"Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2016-04","conditions":"End-Stage Renal Disease","enrollment":76},{"nctId":"NCT06225206","phase":"","title":"Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients","status":"UNKNOWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":"Liver Transplant Failure","enrollment":300},{"nctId":"NCT05666336","phase":"PHASE4","title":"Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients","status":"UNKNOWN","sponsor":"Fen Li","startDate":"2022-12-31","conditions":"Systemic Lupus Erythematosus","enrollment":30},{"nctId":"NCT06178146","phase":"PHASE4","title":"Thymosin Alpha-1 for irAE Secondary to ICIs","status":"UNKNOWN","sponsor":"Jun Wang","startDate":"2023-09-01","conditions":"IrAE","enrollment":40},{"nctId":"NCT02409147","phase":"NA","title":"Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2016-01","conditions":"Uterus Transplant","enrollment":""},{"nctId":"NCT02416674","phase":"EARLY_PHASE1","title":"Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2015-03-01","conditions":"Abdominal Wall Defect","enrollment":10},{"nctId":"NCT04414735","phase":"NA","title":"Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients","status":"UNKNOWN","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Kidney Transplant Rejection","enrollment":30},{"nctId":"NCT01650545","phase":"PHASE1, PHASE2","title":"Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2012-07","conditions":"Disorder Related to Lung Transplantation, Bronchiolitis Obliterans, Decreased Immunologic Activity","enrollment":21},{"nctId":"NCT04415476","phase":"PHASE2","title":"Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2020-06-30","conditions":"Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant, Decreased Immunologic Activity","enrollment":""},{"nctId":"NCT03468478","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation","status":"COMPLETED","sponsor":"Hospital do Rim e Hipertensão","startDate":"2017-06-18","conditions":"Kidney Transplant Infection","enrollment":1209},{"nctId":"NCT04903054","phase":"PHASE2","title":"Selective CD28 Blockade in Renal Transplant Recipients","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-01-10","conditions":"Kidney Transplantation, Renal Transplant Recipients","enrollment":""},{"nctId":"NCT03438773","phase":"PHASE1","title":"Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients","status":"UNKNOWN","sponsor":"California Institute of Renal Research","startDate":"2018-07-11","conditions":"Kidney Transplant; Complications, Kidney Transplant Failure and Rejection","enrollment":50},{"nctId":"NCT05061303","phase":"","title":"Omeprazole and Famotidine in Chronic Dysfunction of the Transplanted Kidney","status":"UNKNOWN","sponsor":"Poznan University of Medical Sciences","startDate":"2021-10-17","conditions":"Kidney Rejection Transplant","enrollment":24},{"nctId":"NCT02909335","phase":"PHASE3","title":"De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study","status":"WITHDRAWN","sponsor":"Rennes University Hospital","startDate":"2016-11","conditions":"Liver Transplantation","enrollment":""},{"nctId":"NCT03388008","phase":"PHASE2","title":"Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-12-17","conditions":"Lung Transplant Rejection, Antibody-mediated Rejection","enrollment":27},{"nctId":"NCT04431219","phase":"PHASE1, PHASE2","title":"First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients","status":"COMPLETED","sponsor":"Xenothera SAS","startDate":"2019-11-26","conditions":"Kidney Transplant","enrollment":10},{"nctId":"NCT02495077","phase":"PHASE2","title":"Effects of Inhibiting Early Inflammation in Kidney Transplant Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-11-02","conditions":"Kidney Transplant","enrollment":290},{"nctId":"NCT02088931","phase":"PHASE1","title":"Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-03","conditions":"Late Complication From Kidney Transplant","enrollment":3},{"nctId":"NCT03099122","phase":"PHASE4","title":"A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-08-16","conditions":"End-stage Renal Disease","enrollment":115},{"nctId":"NCT00136903","phase":"PHASE2","title":"Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2005-04-27","conditions":"Graft Vs Host Disease","enrollment":32},{"nctId":"NCT03194321","phase":"PHASE4","title":"Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-09-11","conditions":"End Stage Renal Disease","enrollment":20},{"nctId":"NCT04101578","phase":"","title":"Clinical Prognosis and Progression of Myasthenia Gravis Patients","status":"UNKNOWN","sponsor":"Da, Yuwei, M.D.","startDate":"2017-02-08","conditions":"Myasthenia Gravis","enrollment":2000},{"nctId":"NCT01729494","phase":"PHASE4","title":"Belatacept Early Steroid Withdrawal Trial","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2012-09","conditions":"Renal Transplantation","enrollment":316},{"nctId":"NCT02137239","phase":"PHASE2","title":"Regimen Optimization Study","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-12-31","conditions":"Kidney Transplantation","enrollment":58},{"nctId":"NCT01653847","phase":"NA","title":"Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-02","conditions":"End Stage Renal Failure With Renal Transplant","enrollment":88},{"nctId":"NCT01921218","phase":"PHASE3","title":"Belatacept Therapy for the Failing Renal Allograft","status":"COMPLETED","sponsor":"Andrew B Adams","startDate":"2013-08","conditions":"Failing Renal Allograft","enrollment":13},{"nctId":"NCT02188719","phase":"PHASE1","title":"Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-12-17","conditions":"Liver Transplantation","enrollment":15},{"nctId":"NCT00377962","phase":"PHASE4","title":"Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-12","conditions":"Disorder Related to Cardiac Transplantation","enrollment":282},{"nctId":"NCT03828682","phase":"PHASE4","title":"Veloxis de Novo Kidney Transplant ECSWD","status":"UNKNOWN","sponsor":"Simon Tremblay, PharmD, PhD","startDate":"2019-06-21","conditions":"Kidney Transplantation, Immunosuppression","enrollment":60},{"nctId":"NCT02284464","phase":"PHASE4","title":"Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2015-02","conditions":"Other Complication of Kidney Transplant, Renal Transplant Rejection","enrollment":230},{"nctId":"NCT00656266","phase":"PHASE4","title":"Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2004-11","conditions":"End-stage Liver Disease, Renal Insufficiency, Renal Failure","enrollment":13},{"nctId":"NCT01239472","phase":"PHASE4","title":"Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant","status":"COMPLETED","sponsor":"Andre Barreto Pereira","startDate":"2011-01","conditions":"Renal Transplant Rejection, Immunosuppression","enrollment":30},{"nctId":"NCT02953873","phase":"PHASE4","title":"Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-05-05","conditions":"Immunosuppression","enrollment":25},{"nctId":"NCT02954198","phase":"NA","title":"Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-12-01","conditions":"Immunosuppression","enrollment":40},{"nctId":"NCT03315052","phase":"PHASE4","title":"Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2019-01","conditions":"Acute Cellular Graft Rejection, Liver Transplant Rejection","enrollment":""},{"nctId":"NCT01327573","phase":"PHASE1","title":"Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation","status":"COMPLETED","sponsor":"Sanjay Kulkarni","startDate":"2011-03","conditions":"Kidney; Complications, Allograft","enrollment":16},{"nctId":"NCT00866879","phase":"PHASE4","title":"Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2007-06","conditions":"Renal Transplant Rejection","enrollment":275},{"nctId":"NCT03791827","phase":"","title":"Multicenter Registry of Pediatric Lupus Nephritis in China","status":"UNKNOWN","sponsor":"Xiqiang Dang","startDate":"2018-12-01","conditions":"Lupus Nephritis, Children, Steroid","enrollment":1200},{"nctId":"NCT00407160","phase":"","title":"A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2004-08","conditions":"Kidney Diseases","enrollment":21},{"nctId":"NCT02084446","phase":"PHASE4","title":"Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant","status":"COMPLETED","sponsor":"Ronaldo de Matos Esmeraldo, MD","startDate":"2012-12","conditions":"Transplantation Infection, Cytomegalovirus Infections","enrollment":120},{"nctId":"NCT00135694","phase":"PHASE2","title":"Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2005-10","conditions":"Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure","enrollment":275},{"nctId":"NCT01950819","phase":"PHASE4","title":"Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-12-03","conditions":"End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD), Hemodialysis","enrollment":2037},{"nctId":"NCT02130817","phase":"PHASE4","title":"Belatacept in Kidney Transplantation of Moderately Sensitized Patients","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2014-09-24","conditions":"End Stage Renal Disease, Antibody Mediated Rejection","enrollment":""},{"nctId":"NCT02029638","phase":"PHASE2","title":"BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-01-07","conditions":"Kidney Transplantation","enrollment":4},{"nctId":"NCT01580865","phase":"NA","title":"Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis","status":"COMPLETED","sponsor":"Ramathibodi Hospital","startDate":"2012-05","conditions":"Lupus Nephritis","enrollment":84},{"nctId":"NCT02702960","phase":"PHASE2","title":"Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)","status":"WITHDRAWN","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2016-03","conditions":"Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant), Hepatocellular Carcinoma","enrollment":""},{"nctId":"NCT02581436","phase":"NA","title":"Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2014-09","conditions":"Disorder Related to Renal Transplantation, Renal Transplant Rejection, Acute Graft Rejection","enrollment":70},{"nctId":"NCT00275509","phase":"PHASE3","title":"Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2007-01","conditions":"Kidney Failure, Chronic","enrollment":56},{"nctId":"NCT01884571","phase":"PHASE2","title":"Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-10","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":31},{"nctId":"NCT01517984","phase":"PHASE2","title":"Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-11","conditions":"Kidney Transplant Recipients","enrollment":52},{"nctId":"NCT01895049","phase":"PHASE4","title":"Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria","status":"COMPLETED","sponsor":"Helio Tedesco Silva Junior","startDate":"2013-08","conditions":"Kidney Transplantation, Cytomegalovirus","enrollment":171},{"nctId":"NCT01276834","phase":"PHASE4","title":"Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation","status":"TERMINATED","sponsor":"Dianet Dialysis Centers","startDate":"2010-09","conditions":"Renal Transplantation","enrollment":13},{"nctId":"NCT00157014","phase":"PHASE3","title":"Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2004-05-10","conditions":"Heart Diseases, Heart Transplantation","enrollment":111},{"nctId":"NCT00596947","phase":"PHASE4","title":"Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2005-10","conditions":"Transplants and Implants","enrollment":18},{"nctId":"NCT01005316","phase":"","title":"Alloantibodies in Pediatric Heart Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-01","conditions":"Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients","enrollment":290},{"nctId":"NCT02058875","phase":"PHASE4","title":"Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2014-02","conditions":"Cardiovascular Disease, Cardiovascular Outcomes, Kidney Transplant Recipients","enrollment":""},{"nctId":"NCT00141037","phase":"PHASE1, PHASE2","title":"Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-03","conditions":"Kidney Diseases, Kidney Transplantation, Kidney Transplant","enrollment":130},{"nctId":"NCT00132691","phase":"PHASE4","title":"Multicenter Uveitis Steroid Treatment (MUST) Trial","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2005-09","conditions":"Uveitis","enrollment":255},{"nctId":"NCT02671318","phase":"PHASE4","title":"Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence","status":"UNKNOWN","sponsor":"Hospital do Rim e Hipertensão","startDate":"2015-09","conditions":"Cytomegalovirus Infections","enrollment":250},{"nctId":"NCT01624948","phase":"PHASE4","title":"Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-09","conditions":"BK Virus Infection","enrollment":40},{"nctId":"NCT02741102","phase":"NA","title":"Uterine Transplant in Absolute Uterine Infertility (AUIF)","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2016-06","conditions":"Female Infertility","enrollment":10},{"nctId":"NCT02683291","phase":"PHASE4","title":"Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients","status":"COMPLETED","sponsor":"Associação Médico Espírita de Botucatu","startDate":"2014-01","conditions":"Disorder Related to Renal Transplantation, Cytomegalovirus Infections","enrollment":48},{"nctId":"NCT00617604","phase":"PHASE2","title":"A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2007-12","conditions":"De Novo Kidney Transplantation","enrollment":218},{"nctId":"NCT00374231","phase":"PHASE4","title":"Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2002-10","conditions":"Liver Transplantation","enrollment":40},{"nctId":"NCT02208791","phase":"PHASE4","title":"Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-07","conditions":"Kidney Transplantation","enrollment":45},{"nctId":"NCT00543569","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2008-02","conditions":"Kidney Transplantation","enrollment":323},{"nctId":"NCT01631058","phase":"PHASE4","title":"Renal Transplantation in the Elderly - nEverOld Study","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2012-07","conditions":"Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney","enrollment":90},{"nctId":"NCT00707759","phase":"PHASE3","title":"Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection","status":"COMPLETED","sponsor":"Fondo Nacional de Desarrollo Científico y Tecnológico, Chile","startDate":"2008-06","conditions":"Kidney Diseases","enrollment":28},{"nctId":"NCT00166712","phase":"PHASE4","title":"A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2005-04","conditions":"Kidney Transplant Failure and Rejection","enrollment":40},{"nctId":"NCT02561767","phase":"PHASE1, PHASE2","title":"Effect of BM-MSCs in DCD Kidney Transplantation","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-10","conditions":"Kidney Transplantation, Acute Kidney Tubular Necrosis","enrollment":120},{"nctId":"NCT01469884","phase":"PHASE4","title":"Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients","status":"COMPLETED","sponsor":"Irmandade Santa Casa de Misericórdia de Porto Alegre","startDate":"2011-11","conditions":"Renal Allograft, Hepatitis C","enrollment":30},{"nctId":"NCT01354301","phase":"PHASE4","title":"Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate","status":"COMPLETED","sponsor":"Hospital do Rim e Hipertensão","startDate":"2011-05","conditions":"Cytomegalovirus Infection, Renal Transplant Failure, Transplant; Complication, Rejection","enrollment":300},{"nctId":"NCT02328222","phase":"PHASE4","title":"ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION","status":"COMPLETED","sponsor":"Unidad de Investigacion Medica en Enfermedades Renales","startDate":"2010-06","conditions":"END STAGE RENAL DISEASE","enrollment":71},{"nctId":"NCT02291770","phase":"PHASE3","title":"Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells","status":"UNKNOWN","sponsor":"Guangdong Provincial People's Hospital","startDate":"2014-10","conditions":"Chronic Graft-Versus-Host Disease","enrollment":130},{"nctId":"NCT00724022","phase":"PHASE4","title":"Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation","status":"COMPLETED","sponsor":"University Hospital Freiburg","startDate":"2008-06","conditions":"Disorder Related to Renal Transplantation","enrollment":600},{"nctId":"NCT00885820","phase":"PHASE4","title":"Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2001-09","conditions":"Kidney Transplantation","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Myfortic","Tacrolimus","Prednisone"],"phase":"marketed","status":"active","brandName":"Mycophenolate+Tacrolimus+Prednisone","genericName":"Mycophenolate+Tacrolimus+Prednisone","companyName":"Fundação Pró Rim","companyId":"funda-o-pr-rim","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This triple immunosuppressive regimen suppresses T-cell proliferation and activation to prevent organ rejection after transplantation. Used for Prevention of organ rejection in renal transplant recipients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}